Baxter International Inc. (BAX)
| Market Cap | 19.61B |
| Revenue (ttm) | 14.95B |
| Net Income (ttm) | 2.59B |
| Shares Out | 507.32M |
| EPS (ttm) | 5.11 |
| PE Ratio | 7.57 |
| Forward PE | 12.72 |
| Dividend | $1.16 (3.00%) |
| Ex-Dividend Date | Nov 30, 2023 |
| Volume | 2,475,421 |
| Open | 38.72 |
| Previous Close | 38.80 |
| Day's Range | 38.60 - 38.99 |
| 52-Week Range | 31.01 - 53.12 |
| Beta | 0.61 |
| Analysts | Buy |
| Price Target | 47.23 (+22.17%) |
| Earnings Date | Feb 8, 2024 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical pr... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 14 analysts, the average rating for BAX stock is "Buy." The 12-month stock price forecast is $47.23, which is an increase of 22.17% from the latest price.
News
Spectral Medical Provides Tigris Trial Update
TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, t...
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV)...
Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe...
Strategist: Buy Baxter stock, skip Eli Lilly stock
Novo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype.
Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North America
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its first report aligned with the Task Force on Climate-related Financial Disclosures (...
The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt
DEERFIELD, Ill. & NEW YORK--(BUSINESS WIRE)--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve ac...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share o...
Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter's Sharesource remote patie...
Baxter International beats Q3 profit estimates on strong demand for medical devices
Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after the pandemic helped drive the demand for its medi...
Baxter Reports Third-Quarter 2023 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2023. “Baxter continues to successfully execute upon th...
The Value Deepens for Medtech Stocks: Reversal Imminent
Results from Johnson & Johnson NYSE: JNJ and Abbott Laboratories NYSE: ABT foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength...
BAXTER ALERT: Bragar Eagel & Squire, P.C. is Investigating Baxter International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Baxter International, Inc. (NYSE: BAX) on be...
What other industries could weight loss drugs disrupt?
Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
Is the euphoria around these drugs really warranted?
Dr. Kavita Patel, joins the ‘Fast Money' traders to discuss the obesity drug euphoria.
Dialysis company shares plunge after Ozempic trial success vs. kidney trouble
The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.
Baxter Appoints Joel Grade Chief Financial Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CF...
Advent International and Warburg Pincus Complete Acquisition of Baxter's BioPharma Solutions Business
BOSTON & NEW YORK--(BUSINESS WIRE)--Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, toda...
Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2023 financial results on Thursday, November 2...
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Baxter International Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securitie...
SHAREHOLDER ALERT: Potential Recovery for Baxter International Inc. (BAX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Baxter International Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securitie...
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Baxter Investors of a Lead Plaintiff Deadline of September 11, 2023
NEW YORK , Sept. 11, 2023 /PRNewswire/ -- Attention Baxter International Inc. ("Baxter") (NYSE: BAX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on...
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International Inc. (BAX)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 11, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inve...
DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. ("B...